+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Desmopressin Market - Global Forecast 2026-2032- Product Image
Desmopressin Market - Global Forecast 2026-2032- Product Image
New

Desmopressin Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083053
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The desmopressin market is evolving in response to diversified clinical needs and shifting healthcare delivery models, with both formulation innovation and supply resilience now central to success for senior decision-makers. Strategic alignment across regions, patient pathways, and distribution channels is vital as stakeholders strive to achieve sustainable growth.

Market Snapshot

The Desmopressin Market grew from USD 1.40 billion in 2025 to USD 1.50 billion in 2026. It is expected to continue growing at a CAGR of 7.29%, reaching USD 2.29 billion by 2032. This upward trajectory is shaped by the expansion of outpatient care, increased formulation options, and heightened attention to both real-world outcomes and supply chain stability, driving a notable change in how therapies are delivered and accessed.

Scope & Segmentation

  • Clinical Indications: Bleeding disorders (Hemophilia A, Von Willebrand Disease), central diabetes insipidus, and lower urinary tract dysfunction, including nocturia.
  • Formulation Types: Injectable (intravenous, subcutaneous), intranasal spray, and oral tablet options cater to varied clinical and patient needs.
  • Administration Settings: Hospitals (private, public), clinics, and differentiated home care environments, with growing emphasis on patient empowerment and outpatient pathways.
  • Distribution Channels: Offline retail (specialty stores, health and wellness outlets, supermarkets), online retail (company platforms, e-commerce sites).
  • Geographic Regions: Americas, Europe Middle East & Africa, Asia-Pacific—with each region characterized by its own regulatory, reimbursement, and manufacturing landscape.

Key Takeaways

  • Desmopressin’s clinical significance is underpinned by its ability to serve diverse therapeutic domains, targeting both water balance disorders and bleeding diatheses.
  • Formulation and administration diversity drive adoption across ambulatory, inpatient, and home settings, as both patient and provider preferences continue to shift toward convenience and safety.
  • Innovation in the development of newer routes of administration, including simplified oral formulations, enables broader outpatient and self-managed use cases, supporting decentralized care models.
  • Regulatory and payer priorities now increasingly focus on real-world evidence and value-added outcomes, influencing both market access and product lifecycle strategies.
  • Competitive differentiation is moving beyond price, centering on integrated service offerings, supply assurance, and value through patient support and education initiatives.
  • Cross-regional collaboration, supply chain agility, and evidence-driven clinical support are emerging as key levers for manufacturers and institutional buyers navigating evolving landscape demands.

Tariff Impact

Tariff adjustments are generating cascading effects across sourcing, production, and procurement functions. Increased import costs are prompting both manufacturers and buyers to evaluate production localization, expand supplier networks, and prioritize products demonstrating supply continuity. Hospitals and payers are shifting toward value-driven procurement practices, incentivizing bundled services, lower total therapy costs, and transparent supply commitments to mitigate disruption risks.

Desmopressin Market: Research Methodology & Data Sources

Our analysis integrates structured clinician interviews, procurement leader insights, and regulatory document review. Triangulation across primary and secondary data ensures comprehensive and validated findings on prescribing behaviors, formulation use, and logistics challenges.

Why This Report Matters

  • Enables strategic investment in resilient supply chains and regional manufacturing, safeguarding access and minimizing operational risk.
  • Informs decision-making on competitive positioning by highlighting formulation advancements, differentiated support services, and evolving payer requirements.
  • Delivers actionable intelligence for aligning product, pricing, and partnership tactics to variable global distribution landscapes and clinical expectations.

Conclusion

Desmopressin’s expanding role is shaped by ongoing innovation, regulatory changes, and regional market dynamics. By focusing on patient-centric delivery, cost-effective value, and integrated support, industry leaders can strengthen market presence and continuity of care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Desmopressin Market, by Indication
8.1. Bleeding Disorders
8.1.1. Hemophilia A
8.1.2. Von Willebrand Disease
8.2. Central Diabetes Insipidus
8.3. Nocturia
9. Desmopressin Market, by Product Type
9.1. Injection
9.1.1. Intravenous Injection
9.1.2. Subcutaneous Injection
9.2. Intranasal Spray
9.3. Oral Tablet
10. Desmopressin Market, by Route Of Administration
10.1. Intranasal
10.2. Intravenous Injection
10.3. Oral
10.4. Subcutaneous Injection
11. Desmopressin Market, by Distribution Channel
11.1. Offline Retail
11.1.1. Health & Wellness Stores
11.1.2. Specialty Stores
11.1.3. Supermarkets/Hypermarkets
11.2. Online Retail
11.2.1. Company Websites
11.2.2. E-commerce Platforms
12. Desmopressin Market, by End User
12.1. Clinics
12.2. Home Care Settings
12.2.1. Home Care Nursing
12.2.2. Self Administration
12.3. Hospitals
12.3.1. Private Hospitals
12.3.2. Public Hospitals
13. Desmopressin Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Desmopressin Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Desmopressin Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Desmopressin Market
17. China Desmopressin Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AA Pharma Inc.
18.6. Amring Pharmaceuticals Inc.
18.7. Antares Pharma, Inc. by Halozyme, Inc.
18.8. Apotex Inc.
18.9. Avadel Pharmaceuticals PLC
18.10. Bachem AG
18.11. BluePoint Laboratories
18.12. CSC Pharmaceuticals International
18.13. Dr. Reddy's Laboratories Ltd.
18.14. Enomark
18.15. Ferring Pharmaceuticals
18.16. Glenmark Pharmaceuticals Limited
18.17. Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
18.18. KVR Pharmaceuticals
18.19. Manus Aktteva Biopharma LLP
18.20. Midas Pharma GmbH
18.21. NorthStar Rx LLC
18.22. Pfizer Inc.
18.23. Ralington Pharma LLP
18.24. Saintroy Lifescience
18.25. Sanofi S.A.
18.26. Sava Healthcare Limited
18.27. Sun Pharmaceutical Industries Limited
18.28. Teva Pharmaceutical Industries Ltd.
18.29. VIVAN Life Sciences Pvt. Limited
List of Figures
FIGURE 1. GLOBAL DESMOPRESSIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DESMOPRESSIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DESMOPRESSIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES DESMOPRESSIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA DESMOPRESSIN MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DESMOPRESSIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DESMOPRESSIN MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DESMOPRESSIN MARKET SIZE, BY HEMOPHILIA A, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DESMOPRESSIN MARKET SIZE, BY HEMOPHILIA A, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DESMOPRESSIN MARKET SIZE, BY VON WILLEBRAND DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DESMOPRESSIN MARKET SIZE, BY VON WILLEBRAND DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DESMOPRESSIN MARKET SIZE, BY VON WILLEBRAND DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DESMOPRESSIN MARKET SIZE, BY CENTRAL DIABETES INSIPIDUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DESMOPRESSIN MARKET SIZE, BY CENTRAL DIABETES INSIPIDUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DESMOPRESSIN MARKET SIZE, BY CENTRAL DIABETES INSIPIDUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DESMOPRESSIN MARKET SIZE, BY NOCTURIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DESMOPRESSIN MARKET SIZE, BY NOCTURIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DESMOPRESSIN MARKET SIZE, BY NOCTURIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DESMOPRESSIN MARKET SIZE, BY INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DESMOPRESSIN MARKET SIZE, BY INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DESMOPRESSIN MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRAVENOUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRAVENOUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DESMOPRESSIN MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DESMOPRESSIN MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DESMOPRESSIN MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRANASAL SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRANASAL SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRANASAL SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DESMOPRESSIN MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DESMOPRESSIN MARKET SIZE, BY ORAL TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DESMOPRESSIN MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRANASAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRANASAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRAVENOUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DESMOPRESSIN MARKET SIZE, BY INTRAVENOUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DESMOPRESSIN MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DESMOPRESSIN MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DESMOPRESSIN MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DESMOPRESSIN MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DESMOPRESSIN MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DESMOPRESSIN MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DESMOPRESSIN MARKET SIZE, BY HEALTH & WELLNESS STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DESMOPRESSIN MARKET SIZE, BY HEALTH & WELLNESS STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DESMOPRESSIN MARKET SIZE, BY HEALTH & WELLNESS STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DESMOPRESSIN MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DESMOPRESSIN MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DESMOPRESSIN MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DESMOPRESSIN MARKET SIZE, BY SUPERMARKETS/HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DESMOPRESSIN MARKET SIZE, BY SUPERMARKETS/HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DESMOPRESSIN MARKET SIZE, BY SUPERMARKETS/HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DESMOPRESSIN MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DESMOPRESSIN MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DESMOPRESSIN MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DESMOPRESSIN MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DESMOPRESSIN MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DESMOPRESSIN MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DESMOPRESSIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DESMOPRESSIN MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DESMOPRESSIN MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOME CARE NURSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOME CARE NURSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOME CARE NURSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DESMOPRESSIN MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DESMOPRESSIN MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DESMOPRESSIN MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DESMOPRESSIN MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DESMOPRESSIN MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DESMOPRESSIN MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DESMOPRESSIN MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DESMOPRESSIN MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DESMOPRESSIN MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS DESMOPRESSIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 146. EUROPE DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPE DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPE DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 153. EUROPE DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 154. EUROPE DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 155. EUROPE DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. EUROPE DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 170. AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. AFRICA DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 172. AFRICA DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 173. AFRICA DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 174. AFRICA DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 175. AFRICA DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 176. AFRICA DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. AFRICA DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 178. AFRICA DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 179. AFRICA DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. AFRICA DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 181. AFRICA DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL DESMOPRESSIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. ASEAN DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. ASEAN DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 197. ASEAN DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 198. ASEAN DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 199. ASEAN DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 200. ASEAN DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 201. ASEAN DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 202. ASEAN DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 203. ASEAN DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 204. ASEAN DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. ASEAN DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 206. ASEAN DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 207. GCC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. GCC DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 209. GCC DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 210. GCC DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 211. GCC DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 212. GCC DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. GCC DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 214. GCC DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 215. GCC DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 216. GCC DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. GCC DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 218. GCC DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 231. BRICS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. BRICS DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 233. BRICS DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 234. BRICS DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 235. BRICS DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 236. BRICS DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 237. BRICS DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 238. BRICS DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 239. BRICS DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 240. BRICS DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. BRICS DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 242. BRICS DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 243. G7 DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. G7 DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 245. G7 DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 246. G7 DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. G7 DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 248. G7 DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 249. G7 DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 250. G7 DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 251. G7 DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 252. G7 DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. G7 DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 254. G7 DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 255. NATO DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. NATO DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 257. NATO DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 258. NATO DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 259. NATO DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 260. NATO DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 261. NATO DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 262. NATO DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 263. NATO DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 264. NATO DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. NATO DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 266. NATO DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES DESMOPRESSIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 280. CHINA DESMOPRESSIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. CHINA DESMOPRESSIN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 282. CHINA DESMOPRESSIN MARKET SIZE, BY BLEEDING DISORDERS, 2018-2032 (USD MILLION)
TABLE 283. CHINA DESMOPRESSIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 284. CHINA DESMOPRESSIN MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 285. CHINA DESMOPRESSIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 286. CHINA DESMOPRESSIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 287. CHINA DESMOPRESSIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 288. CHINA DESMOPRESSIN MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 289. CHINA DESMOPRESSIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. CHINA DESMOPRESSIN MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 291. CHINA DESMOPRESSIN MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Desmopressin market report include:
  • AA Pharma Inc.
  • Amring Pharmaceuticals Inc.
  • Antares Pharma, Inc. by Halozyme, Inc.
  • Apotex Inc.
  • Avadel Pharmaceuticals PLC
  • Bachem AG
  • BluePoint Laboratories
  • CSC Pharmaceuticals International
  • Dr. Reddy's Laboratories Ltd.
  • Enomark
  • Ferring Pharmaceuticals
  • Glenmark Pharmaceuticals Limited
  • Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
  • KVR Pharmaceuticals
  • Manus Aktteva Biopharma LLP
  • Midas Pharma GmbH
  • NorthStar Rx LLC
  • Pfizer Inc.
  • Ralington Pharma LLP
  • Saintroy Lifescience
  • Sanofi S.A.
  • Sava Healthcare Limited
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • VIVAN Life Sciences Pvt. Limited

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.5 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.29 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Desmopressin - Global Strategic Business Report - Product Image

Desmopressin - Global Strategic Business Report

  • Report
  • 183 Pages
  • Global
From
Desmopressin (DDAVP) Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Desmopressin (DDAVP) Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 96 Pages
  • Global
From
Desmopressin Acetate Tablets Market - Global Forecast 2026-2032 - Product Image

Desmopressin Acetate Tablets Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Antidiuretic Drugs - Global Strategic Business Report - Product Image

Antidiuretic Drugs - Global Strategic Business Report

  • Report
  • 178 Pages
  • Global
From
Posterior Pituitary for Injection Market - Global Forecast 2025-2030 - Product Image

Posterior Pituitary for Injection Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From

About the Desmopressin Market

Desmopressin is a synthetic analogue of the natural hormone arginine vasopressin, used to treat endocrine and metabolic disorders. It is used to treat diabetes insipidus, a condition in which the body does not produce enough antidiuretic hormone, resulting in excessive urination and dehydration. It is also used to treat nocturnal enuresis, or bedwetting, in children. Desmopressin is available in tablet, intranasal spray, and injection forms. Desmopressin is also used to treat von Willebrand disease, a bleeding disorder caused by a deficiency of von Willebrand factor. It is used to increase the level of von Willebrand factor in the blood, allowing it to clot more effectively. Desmopressin is a widely used drug in the endocrine and metabolic disorders market. It is available from many pharmaceutical companies, including Novartis, Pfizer, and Merck. It is also available in generic forms from many generic drug manufacturers. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.